PT  - JOURNAL ARTICLE
AU  - Mann, Kate
ED  - Stenlöf, Kaj
TI  - Long-term Canagliflozin is Efficacious and Generally Well Tolerated in Older Patients
DP  - 2014 Dec 01
TA  - MD Conference Express
PG  - 9--10
VI  - 14
IP  - 32
4099  - http://mdc.sagepub.com/content/14/32/9.short
4100  - http://mdc.sagepub.com/content/14/32/9.full
AB  - Treatment of the older patients with T2DM can be complex given that these patients often have advanced T2DM, multiple comorbidities, and need combination therapy. This article presents the results of a double-blind phase 3 study of the sodium-glucose cotransporter 2 inhibitor canagliflozin in patients aged 55 to 80 years.